This federal contract award, with an ID of SPE2DX15D3001|SPE2DX24F4SA5, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of OPZELURA 1.5% CREAM 60GM, a pharmaceutical product, with a ceiling value of $7,719.99 and a completion date of April 26, 2024. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) valued at up to...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of OPZELURA 1.5% CREAM 60GM, with a ceiling value of $9,571.46 and a completion date of May 4, 2023. The contract is a firm fixed-price delivery order, without any set-aside designation, indicating open competition. Amerisourcebergen Drug Corp has a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
The Department of the Army Medical Command awarded a definitive cost-no-fee contract to Ashvattha Therapeutics, LLC, a for-profit limited liability company, to support the Temporary Corneal Repair (TCR) program and the Food and Drug Administration (FDA) clearance/approval of a temporary, non-surgical solution to close open globe, full thickness corneal wounds. The contract, valued at $4,249,654.44, requires the vendor to engage the FDA and conduct Good Laboratory Practice (GLP) animal studies,...
This federal contract award is for the delivery of a PHYSICAL THERAPY LASER by LITECURE, LLC, a small business manufacturer of medical devices under its Lightforce Therapy Lasers division. The $28,021.10 firm fixed price award was made by the AIR MOBILITY COMMAND, a component of the U.S. DEPARTMENT OF DEFENSE, and is set aside for total small business participation. The laser system will be delivered to Newark, DE. Litecure, LLC has received prior federal contract awards from the Defense...
The U.S. Food and Drug Administration (FDA) awarded a $84,250.00 purchase order to Terumo BCT Inc. for a "Brand Name or Equal" Terumo Blood and Cell Technologies (BCT), Mirasol Illuminator, Ultraviolet (UV)/Riboflavin Whole Blood Pathogen Reduction Device. This device will be used by the FDA's Center for Biologics Research and Review (CBER), Office of Blood Research and Review (OBRR) to treat whole blood with and without inoculation of model pathogens as a control for evaluating...
This is a federal delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $5,997.76 firm fixed-price contract is for the supply of the prescription drug OPZELURA 1.5% Cream, 60 gm. The order has an ultimate completion date of August 27, 2024. AmerisourceBergen holds several Indefinite Delivery Contracts (IDCs) with the DLA Troop Support Medical and the Department of Justice Federal Bureau of Investigation, valued at...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency to Owens & Minor Distribution, Inc., a for-profit medical and surgical supplies distributor. The contract, valued at $27,828.96, is for the delivery of Cerament 18ml bone void fillers. The order will be fulfilled from Owens & Minor's distribution center in Mechanicsville, Virginia, and has a completion date of July 20, 2023. This award is not associated with a set-aside program. However, Owens & Minor...
This firm fixed-price purchase order was awarded by the Department of Health and Human Services (HHS) Office of the Assistant Secretary for Administration to Whitehouse Analytical Laboratories LLC, a subsidiary of Curia Global Inc. (doing business as Amri), for a VIAL STUDY. The award has a potential value of $116,205.00 and a completion date of May 27, 2017. Curia Global Inc. is a leading contract development and manufacturing organization that provides a wide range of pharmaceutical research...
This federal contract award, with ID SPE2DB22D1103|SPE2DB25FTFT0, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of OPZELURA 1.5% CREAM 60GM, a medical product, with a ceiling value of $2,879.38. The contract is a Delivery Order with a Firm Fixed Price pricing type, and the ultimate completion date is February 19, 2025. The contract does not have a set-aside...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a global pharmaceutical distribution company. The contract is for the supply of OPZELURA 1.5% CREAM 60GM, a pharmaceutical product, with a potential value of $5,975.76 and a completion date of February 27, 2024. Amerisourcebergen Drug Corp holds an Indefinite Delivery Contract (IDC) with DLA, valued at up to $999,999,999.00,...